This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Sture A. M. Johnson, MD; Diana D. Parnell, MD
Madison, Wis

Arch Dermatol. 1975;111(4):528.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The paper by Wong and co-authors on low molecular weight dextran therapy for scleroderma in the ARCHIVES (110:419, 1974) supports findings obtained by Dr. Diana D. Parnell and me. In a paper given by me at the American Dermatological Association meeting in May 1967, I reported on our results in 11 patients with scleroderma who were treated with low molecular weight dextran. The series now is 22. We concluded that low molecular weight dextran helps patients with scleroderma. It healed painful, long-lasting ulcers of the extremities as well as relieved the pain brought on by cold (Raynaud phenomena). Often this would occur within hours. Besides this, it increased the range of motion in many joints. The skin temperature determinations, after reflex vasodilatation, indicated increased blood flow.

Sonographic readings showed subtle changes in the harmonic structure of voice patterns. Subjectively, the patient noted an increase in appetite, weight, . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?